JP2007169302A5 - - Google Patents

Download PDF

Info

Publication number
JP2007169302A5
JP2007169302A5 JP2007083117A JP2007083117A JP2007169302A5 JP 2007169302 A5 JP2007169302 A5 JP 2007169302A5 JP 2007083117 A JP2007083117 A JP 2007083117A JP 2007083117 A JP2007083117 A JP 2007083117A JP 2007169302 A5 JP2007169302 A5 JP 2007169302A5
Authority
JP
Japan
Prior art keywords
oligosaccharide conjugate
menc
hib
sequential administration
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007083117A
Other languages
English (en)
Japanese (ja)
Other versions
JP4871770B2 (ja
JP2007169302A (ja
Filing date
Publication date
Priority claimed from GB9422096A external-priority patent/GB9422096D0/en
Application filed filed Critical
Publication of JP2007169302A publication Critical patent/JP2007169302A/ja
Publication of JP2007169302A5 publication Critical patent/JP2007169302A5/ja
Application granted granted Critical
Publication of JP4871770B2 publication Critical patent/JP4871770B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007083117A 1994-11-02 2007-03-27 組み合わせ髄膜炎ワクチン Expired - Fee Related JP4871770B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422096A GB9422096D0 (en) 1994-11-02 1994-11-02 Combined meningitis vaccine
GB9422096.9 1994-11-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51517596A Division JP3989951B2 (ja) 1994-11-02 1995-11-02 組み合わせ髄膜炎ワクチン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010236921A Division JP2011016850A (ja) 1994-11-02 2010-10-21 組み合わせ髄膜炎ワクチン

Publications (3)

Publication Number Publication Date
JP2007169302A JP2007169302A (ja) 2007-07-05
JP2007169302A5 true JP2007169302A5 (OSRAM) 2007-08-16
JP4871770B2 JP4871770B2 (ja) 2012-02-08

Family

ID=10763774

Family Applications (3)

Application Number Title Priority Date Filing Date
JP51517596A Expired - Fee Related JP3989951B2 (ja) 1994-11-02 1995-11-02 組み合わせ髄膜炎ワクチン
JP2007083117A Expired - Fee Related JP4871770B2 (ja) 1994-11-02 2007-03-27 組み合わせ髄膜炎ワクチン
JP2010236921A Withdrawn JP2011016850A (ja) 1994-11-02 2010-10-21 組み合わせ髄膜炎ワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51517596A Expired - Fee Related JP3989951B2 (ja) 1994-11-02 1995-11-02 組み合わせ髄膜炎ワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010236921A Withdrawn JP2011016850A (ja) 1994-11-02 2010-10-21 組み合わせ髄膜炎ワクチン

Country Status (12)

Country Link
US (1) US6251401B1 (OSRAM)
EP (3) EP2204185A1 (OSRAM)
JP (3) JP3989951B2 (OSRAM)
AT (1) ATE246936T1 (OSRAM)
CA (2) CA2689871A1 (OSRAM)
CY (1) CY2423B1 (OSRAM)
DE (1) DE69531501T3 (OSRAM)
DK (1) DK0789587T4 (OSRAM)
ES (1) ES2204967T5 (OSRAM)
GB (1) GB9422096D0 (OSRAM)
PT (1) PT789587E (OSRAM)
WO (1) WO1996014086A1 (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
ATE208629T1 (de) 1996-08-27 2001-11-15 Chiron Corp Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
JP2002508748A (ja) * 1997-05-01 2002-03-19 カイロン コーポレイション アジュバントとしてのウイルス様粒子の使用
EP0983342B1 (en) * 1997-05-28 2007-09-05 Novartis Vaccines and Diagnostics S.r.l. Culture medium with soy bean extract as aminoacid source and no protein complexes of animal origin
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
DK1233784T3 (da) * 1999-12-02 2008-09-01 Novartis Vaccines & Diagnostic Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100898845B1 (ko) * 2000-06-29 2009-05-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 다가 백신 조성물
US7534444B2 (en) 2001-04-17 2009-05-19 Novattis Vaccines And Diagnostics, Inc. Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
MXPA04011249A (es) * 2002-05-14 2005-06-06 Chiron Srl Vacunas mucosales con adyuvante de quitosano y antigenos meningococicos.
US20030124139A1 (en) * 2002-11-20 2003-07-03 Irina Esikova Compositions and methods for stabilizing biological molecules upon lyophilization
JP4827726B2 (ja) 2003-01-30 2011-11-30 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル 複数の髄膜炎菌血清群に対する注射可能ワクチン
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
ES2397923T3 (es) 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos
GB0500787D0 (en) * 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
KR101359953B1 (ko) * 2005-06-27 2014-02-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
WO2008149238A2 (en) * 2007-06-04 2008-12-11 Novartis Ag Formulation of meningitis vaccines
EP2462949A3 (en) * 2007-10-19 2012-09-05 Novartis AG Meningococcal vaccine formulations
WO2009076158A1 (en) 2007-12-07 2009-06-18 Novartis Ag Compositions for inducing immune responses
DK2608805T4 (da) 2010-08-23 2025-06-30 Wyeth Llc STABILE FORMULERINGER AF NEISSERIA MENINGITIDIS rLP2086 ANTIGENER
RU2546873C2 (ru) 2010-09-10 2015-04-10 УАЙТ ЭлЭлСи Нелипидизированные варианты антигенов neisseria meningitidis orf2086
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
PE20190458A1 (es) 2012-03-09 2019-04-01 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas
WO2014136064A2 (en) 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
MX391027B (es) 2015-02-19 2025-03-21 Pfizer Composiciones de neisseria meningitidis y metodos de la misma.
PE20191107A1 (es) 2017-01-31 2019-08-26 Pfizer Composiciones de neisseria meningitidis y metodos respectivos
CN115605222A (zh) 2019-09-27 2023-01-13 辉瑞公司(Us) 脑膜炎奈瑟氏菌组合物及其方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4451446A (en) 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US5628496A (en) 1995-06-07 1997-05-13 Avm, Inc. Pneumatic spring
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions

Similar Documents

Publication Publication Date Title
JP2007169302A5 (OSRAM)
JP2006213929A5 (OSRAM)
IL222346A (en) An immunogenic preparation containing at least two capsular sugars of meningitides n, its use and a vaccine containing it
JP2009524695A5 (OSRAM)
DK1962899T3 (da) Pneumococcus-polysaccharid-konjugat-vaccine
DK1868645T3 (da) Multivalent pneumokok-sakkarid-protein-konjugat-sammensætning
JP2007522094A5 (OSRAM)
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
JP2007533729A5 (OSRAM)
JP2009536652A5 (OSRAM)
JP2009538898A5 (OSRAM)
IL200388A (en) Antibody, antibody hybridoma, antibody-containing conjugate, antibody-containing drug and / or conjugate and their uses
JP2007520565A5 (OSRAM)
JP2006305390A5 (OSRAM)
WO2007083190A8 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
JP2008104450A5 (OSRAM)
EP2076125A4 (en) MODIFIED NDGA DERIVATIVES FROM TETRA-O-SUBSTITUTED BUTANE BRIDGE, THEIR SYNTHESIS AND PHARMACEUTICAL USE
JP2008519810A5 (OSRAM)
JP2008533990A5 (OSRAM)
EP2292241A4 (en) SCUTELLARIN DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE
ATE466863T1 (de) Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин
JP2009509934A5 (OSRAM)
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
During SUPER HOT